Ad is loading...
CLPBY
Price
$12.78
Change
-$0.10 (-0.78%)
Updated
Nov 15 closing price
78 days until earnings call
SMMNY
Price
$26.33
Change
+$0.12 (+0.46%)
Updated
Nov 15 closing price
80 days until earnings call
Ad is loading...

CLPBY vs SMMNY

Header iconCLPBY vs SMMNY Comparison
Open Charts CLPBY vs SMMNYBanner chart's image
Coloplast AS
Price$12.78
Change-$0.10 (-0.78%)
Volume$91.19K
CapitalizationN/A
Siemens Healthineers AG
Price$26.33
Change+$0.12 (+0.46%)
Volume$83.05K
CapitalizationN/A
CLPBY vs SMMNY Comparison Chart
Loading...
CLPBY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SMMNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CLPBY vs. SMMNY commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CLPBY is a StrongBuy and SMMNY is a StrongBuy.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (CLPBY: $12.78 vs. SMMNY: $26.33)
Brand notoriety: CLPBY and SMMNY are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: CLPBY: 141% vs. SMMNY: 174%
Market capitalization -- CLPBY: $26.46B vs. SMMNY: $65B
CLPBY [@Medical Specialties] is valued at $26.46B. SMMNY’s [@Medical Specialties] market capitalization is $65B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.03B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CLPBY’s FA Score shows that 2 FA rating(s) are green whileSMMNY’s FA Score has 1 green FA rating(s).

  • CLPBY’s FA Score: 2 green, 3 red.
  • SMMNY’s FA Score: 1 green, 4 red.
According to our system of comparison, CLPBY is a better buy in the long-term than SMMNY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CLPBY’s TA Score shows that 3 TA indicator(s) are bullish while SMMNY’s TA Score has 5 bullish TA indicator(s).

  • CLPBY’s TA Score: 3 bullish, 5 bearish.
  • SMMNY’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, SMMNY is a better buy in the short-term than CLPBY.

Price Growth

CLPBY (@Medical Specialties) experienced а -2.85% price change this week, while SMMNY (@Medical Specialties) price change was -5.80% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -4.23%. For the same industry, the average monthly price growth was -2.87%, and the average quarterly price growth was -6.14%.

Reported Earning Dates

CLPBY is expected to report earnings on Feb 04, 2025.

SMMNY is expected to report earnings on Feb 06, 2025.

Industries' Descriptions

@Medical Specialties (-4.23% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SMMNY($65B) has a higher market cap than CLPBY($26.5B). SMMNY has higher P/E ratio than CLPBY: SMMNY (38.76) vs CLPBY (36.50). CLPBY YTD gains are higher at: 11.496 vs. SMMNY (-7.890). CLPBY has higher annual earnings (EBITDA): 7.65B vs. SMMNY (3.79B). CLPBY has higher revenues than SMMNY: CLPBY (24.1B) vs SMMNY (21.6B).
CLPBYSMMNYCLPBY / SMMNY
Capitalization26.5B65B41%
EBITDA7.65B3.79B202%
Gain YTD11.496-7.890-146%
P/E Ratio36.5038.7694%
Revenue24.1B21.6B112%
Total CashN/A1.75B-
Total DebtN/A654M-
FUNDAMENTALS RATINGS
CLPBY vs SMMNY: Fundamental Ratings
CLPBY
SMMNY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
9
Undervalued
9
Undervalued
PROFIT vs RISK RATING
1..100
7161
SMR RATING
1..100
2265
PRICE GROWTH RATING
1..100
5460
P/E GROWTH RATING
1..100
6888
SEASONALITY SCORE
1..100
5075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CLPBY's Valuation (9) in the null industry is in the same range as SMMNY (9). This means that CLPBY’s stock grew similarly to SMMNY’s over the last 12 months.

SMMNY's Profit vs Risk Rating (61) in the null industry is in the same range as CLPBY (71). This means that SMMNY’s stock grew similarly to CLPBY’s over the last 12 months.

CLPBY's SMR Rating (22) in the null industry is somewhat better than the same rating for SMMNY (65). This means that CLPBY’s stock grew somewhat faster than SMMNY’s over the last 12 months.

CLPBY's Price Growth Rating (54) in the null industry is in the same range as SMMNY (60). This means that CLPBY’s stock grew similarly to SMMNY’s over the last 12 months.

CLPBY's P/E Growth Rating (68) in the null industry is in the same range as SMMNY (88). This means that CLPBY’s stock grew similarly to SMMNY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CLPBYSMMNY
RSI
ODDS (%)
N/A
Bullish Trend 3 days ago
55%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
61%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bullish Trend 3 days ago
63%
MACD
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
60%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
54%
Bearish Trend 3 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
56%
Bearish Trend 3 days ago
53%
Advances
ODDS (%)
Bullish Trend 11 days ago
69%
Bullish Trend 11 days ago
58%
Declines
ODDS (%)
Bearish Trend 5 days ago
54%
Bearish Trend 4 days ago
54%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
69%
Bullish Trend 3 days ago
73%
Aroon
ODDS (%)
Bearish Trend 3 days ago
52%
Bearish Trend 3 days ago
57%
View a ticker or compare two or three
Ad is loading...
CLPBY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SMMNY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SFAAX43.17-0.36
-0.83%
Allspring Index Asset Allocation A
PFPWX57.79-0.57
-0.98%
Parnassus Value Equity Institutional
MRSPX16.08-0.23
-1.41%
BlackRock Advantage SMID Cap R
UIVPX12.35-0.20
-1.59%
MFS Intrinsic Value R3
BNSCX18.55-0.45
-2.37%
UBS US Small Cap Growth A

CLPBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, CLPBY has been loosely correlated with CLPBF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLPBY jumps, then CLPBF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLPBY
1D Price
Change %
CLPBY100%
-0.78%
CLPBF - CLPBY
38%
Loosely correlated
N/A
SAUHY - CLPBY
34%
Loosely correlated
-1.84%
SMMNY - CLPBY
33%
Poorly correlated
+0.45%
SONVY - CLPBY
32%
Poorly correlated
-0.52%
ESLOY - CLPBY
32%
Poorly correlated
+0.42%
More

SMMNY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SMMNY has been loosely correlated with SAUHY. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SMMNY jumps, then SAUHY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SMMNY
1D Price
Change %
SMMNY100%
+0.45%
SAUHY - SMMNY
48%
Loosely correlated
-1.84%
CZMWY - SMMNY
44%
Loosely correlated
-0.39%
ESLOY - SMMNY
38%
Loosely correlated
+0.42%
ALC - SMMNY
37%
Loosely correlated
-0.05%
PHG - SMMNY
34%
Loosely correlated
+0.39%
More